Half of pharma and biotech companies using AI and big data
A survey conducted by ICON has found sentiment towards artificial intelligence (AI) and digital tools in the clinical research sector…
News
BioArctic doses first subject in Parkinson’s disease therapy trial
Ryvu Therapeutics doses first subject in Phase II myelofibrosis treatment trial
Nuvig secures $161m financing to support clinical studies for NVG-2089
“Systematic reviews” for underrepresented groups in trials needed, says WHO senior adviser
Merus’ Bizengri granted FDA accelerated approval to treat NRG1+ cancers
Cidara achieves full enrolment in influenza prevention trial
Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area
